Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

9480	Companies
185558	Keywords
117947	Articles
99388	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

PRESS RELEASE

published on 06/14/2025 at 00:00, 5 months 21 days ago

Onco-Innovations Engages the University of Alberta and Cross Cancer Institute to Expand PNKP Inhibitor Research into Hard-to-Treat Cancers
Onco-Innovations partners with University of Alberta and Cross Cancer Institute for preclinical study focusing on hard-to-treat cancers, starting with glioblastoma. Research led by Dr. Michael Weinfeld

Preclinical Study Glioblastoma Onco-Innovations University Of Alberta Cross Cancer Institute
BRIEF

published on 06/06/2025 at 00:05, 5 months 29 days ago

Onco-Innovations Launches AI-Oncology Consortium

Personalized Cancer Care Predictive Modeling AI In Oncology Multimodal Data Cross-Sector Collaboration
BRIEF

published on 06/06/2025 at 00:05, 5 months 29 days ago

Onco-Innovations lance un consortium IA-Oncologie

Collaboration Intersectorielle Modélisation Prédictive L'IA En Oncologie Données Multimodales Soins Personnalisés Contre Le Cancer
PRESS RELEASE

published on 06/06/2025 at 00:00, 5 months 29 days ago

Onco-Innovations' Inka Health to Launch Global AI-Oncology Consortium to Advance Predictive Cancer Research
Onco-Innovations Limited's subsidiary, Inka Health Corp., launches PROmAI Consortium for AI in oncology to enhance predictive modeling and collaboration among key stakeholders

Predictive Modeling Onco-Innovations Limited Inka Health Corp. AI In Oncology PROmAI Consortium
BRIEF

published on 05/27/2025 at 00:07, 6 months 9 days ago

Onco-Innovations Advances with Manufacturing for PNKP Inhibitor

Cancer Research Preclinical Testing Onco-Innovations PNKP Inhibitor Dalton Pharma
BRIEF

published on 05/27/2025 at 00:07, 6 months 9 days ago

Onco-Innovations progresse dans la fabrication d'un inhibiteur de la PNKP

Recherche Sur Le Cancer Onco-Innovations Dalton Pharma Inhibiteur De PNKP Tests Précliniques
PRESS RELEASE

published on 05/27/2025 at 00:02, 6 months 9 days ago

Onco-Innovations Announces Start of Manufacturing of Preclinical Testing Material for Its PNKP Inhibitor Technology by Dalton Pharma
Onco-Innovations announces commencement of manufacturing for preclinical testing of nanoparticle-formulated PNKP inhibitor technology in collaboration with Dalton Pharma Services

Manufacturing Preclinical Testing Onco-Innovations Dalton Pharma Services Nanoparticle
BRIEF

published on 05/26/2025 at 15:05, 6 months 10 days ago

Onco-Innovations Extends Marketing Partnership with MCS

Digital Advertising Cancer Research Marketing Partnership Onco-Innovations MCS GmbH
BRIEF

published on 05/26/2025 at 15:05, 6 months 10 days ago

Onco-Innovations étend son partenariat marketing avec MCS

Publicité Numérique Partenariat Marketing Recherche Sur Le Cancer Onco-Innovations MCS GmbH
PRESS RELEASE

published on 05/26/2025 at 15:00, 6 months 10 days ago

Onco-Innovations Extends Marketing Program
Onco-Innovations Limited extends engagement with MCS Market Communication Service GmbH for online marketing services until June 30, 2025. No securities provided as compensation

Digital Channels Onco-Innovations Limited MCS Market Communication Service GmbH Online Marketing Services Engagement Extension

Accesswire

Published on 12/05/2025 at 21:45, 23 minutes ago

When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 38 minutes ago

The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once
Published on 12/05/2025 at 21:20, 48 minutes ago

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Published on 12/05/2025 at 21:00, 1 hour 8 minutes ago

The Repricing Event: Why Multiple Global Industries Are Suddenly Moving Toward SMX
Published on 12/05/2025 at 20:25, 1 hour 43 minutes ago

The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 3 hours 9 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 3 hours 41 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 3 hours 52 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 4 hours 16 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 4 hours 21 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 4 hours 50 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 4 hours 50 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 6 hours 57 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 6 hours 57 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 8 hours 9 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE